Jefferies Adjusts Raffles Medical Group's Price Target to SG$1.10 From SG$1.30, Keeps at Buy
Raffles Medical Group (SGX:BSL) has an average rating of overweight and mean price target of SG$1.07, according to analysts polled by FactSet.
3 stories mentioning SGX:BSLUpdated 50d ago
Every FINWIRES story that references SGX:BSL, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
Raffles Medical Group (SGX:BSL) has an average rating of overweight and mean price target of SG$1.07, according to analysts polled by FactSet.
Singapore shares surged on Monday, tracking broader regional gains as the US and Iran paused attacks on one another for a second consecutive day.The Straits Times Index (STI), a key benchmark for the Singapore Exchange, ranged between 5,549.18 and 5,620.68 throughout the day. It ended the session at 5,620.24, up 31.90 points or 0.6% compared to Friday's close.On the corporate front, shares of Raffles Medical (SGX:BSL) dropped over 4% at the close as its attributable profit to owners dropped 9.6% during the first half of the year to SG$29.0 million from SG$32.1 million a year earlier.iFast's (SGX:AIY) shares closed nearly 3% lower as its net profit after tax rose 35% in the second quarter of the year to SG$29.8 million from SG$22.1 million a year earlier.Far East Orchard's (SGX:O10) 239-bed purpose-built student accommodation development in Manchester, UK, has secured a Gateway 2 approval.
Raffles Medical's (SGX:BSL) attributable profit to owners dropped 9.6% during the first half of the year to SG$29.0 million from SG$32.1 million a year earlier, according to a Monday filing with the Singapore Exchange.Earnings per share fell to SG$0.0157 compared with SG$0.0173 in the year-ago period.Revenue declined 6.7% year over year to SG$353.2 million from SG$378.4 million.Shares of the integrated private healthcare provider slipped over 4% in Monday morning trading.